Related Experiment Videos
Home oxygen therapy for chronic lung disease in extremely low-birth-weight infants
B B Hudak1, M C Allen, M L Hudak
1Eudowood Pediatric Respiratory Science Division, Johns Hopkins University School of Medicine, Baltimore, Md. 21205.
Insights
Extremely low-birth-weight infants with chronic lung disease can safely receive home oxygen therapy. This allows for early discharge and supports their recovery, with good weight gain and survival rates.
Area of Science:
- Neonatology
- Pediatric Pulmonology
- Critical Care Medicine
Background:
- Extremely low-birth-weight (ELBW) infants often develop chronic lung disease requiring prolonged oxygen support.
- Managing these infants' recovery and discharge poses significant challenges for healthcare providers.
- Early discharge is desirable but requires careful consideration of ongoing medical needs.
Purpose of the Study:
- To evaluate the safety and efficacy of home oxygen therapy for ELBW infants with chronic lung disease.
- To assess the outcomes of ELBW infants discharged on supplemental oxygen.
- To determine if supervised home oxygen therapy facilitates early discharge.
Main Methods:
- Follow-up data collected on 30 ELBW infants (birth weight < 1000g) discharged on supplemental oxygen.
- Oxygen therapy aimed to maintain arterial oxygen saturation ≥ 95%.
- Infants monitored through 18.5 months corrected age.
Main Results:
- All 30 infants survived through the follow-up period.
- Mean duration of home oxygen therapy was 4.5 months.
- Weight percentile increased significantly from discharge to follow-up.
- Only 6 infants required hospitalization for acute medical issues.
Conclusions:
- Supervised home oxygen therapy is a safe and effective option for selected ELBW infants with chronic lung disease.
- Early discharge with home oxygen support is feasible and associated with positive outcomes.
- This approach can improve resource utilization and family-centered care.
Abstract:
Chronic lung disease that requires prolonged oxygen therapy commonly complicates the recovery of extremely low-birth-weight infants (less than 1000 g). We report follow-up data through 18.5 +/- 0.9 (mean +/- SEM) months of age in 30 extremely low-birth-weight infants (birth weight, 783 +/- 24 g; gestational age, 26.0 +/- 0.3 weeks) who were discharged home receiving supplemental oxygen. Oxygen was prescribed to maintain arterial oxygen saturation at 95% or greater. At discharge, postconceptional age was 40.5 +/- 0.6 weeks, and weight was 2220 +/- 50 g. Duration of home oxygen therapy was 4.5 +/- 0.5 months. The mean weight percentile increased from less than 5 to 23 between discharge and the last follow-up. All infants survived; only 6 required hospitalization for acute medical illnesses. We conclude that carefully supervised home oxygen therapy permits the safe early discharge of selected extremely low-birth-weight infants with chronic lung disease.